Woburn biotech cuts more than 200 jobs after FDA setback

The layoffs follow the agency’s decision not to approve the company’s advanced melanoma treatment. The post Woburn biotech cuts more than 200 jobs after FDA setback appeared first on Boston.com .

Go to News Site